Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-24 @ 3:22 PM
Study NCT ID:
NCT03997292
Status:
WITHDRAWN
Last Update Posted:
2019-06-25
First Post:
2017-11-14
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Intravenous Thrombolysis Registry for Acute Ischemic Stroke in China
Sponsor:
General Hospital of Shenyang Military Region
Organization:
Study Overview
Official Title:
Intravenous ThrombolysisRegistry for Acute Ischemic Stroke in China
Status:
WITHDRAWN
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study has been terminated due to key change of protocol
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To analyze the real situation of intravenous thrombolysis in acute ischemic stroke in China
Detailed Description:
Compare the efficacy and safety of different thrombolytic drugs; Analysis of patients during hospital treatment of adverse events and complications; Analysis of factors that affect the effectiveness of treatment; Evaluate the pharmacological benefits of different thrombolytic drugs
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: